RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,614,045 | +39.0% | 1,597,123 | 0.0% | 0.98% | +56.5% |
Q2 2023 | $26,336,558 | -7.6% | 1,597,123 | 0.0% | 0.63% | -7.8% |
Q1 2023 | $28,492,674 | -44.4% | 1,597,123 | -9.3% | 0.68% | -44.9% |
Q4 2022 | $51,276,389 | +18.9% | 1,760,865 | 0.0% | 1.23% | +10.8% |
Q3 2022 | $43,141,000 | +640.7% | 1,760,865 | +25.5% | 1.11% | +559.2% |
Q2 2022 | $5,824,000 | -59.1% | 1,403,298 | +13.4% | 0.17% | -52.9% |
Q1 2022 | $14,251,000 | +127.7% | 1,237,026 | +97.2% | 0.36% | +147.6% |
Q4 2021 | $6,259,000 | -21.7% | 627,180 | +2.5% | 0.14% | -13.7% |
Q3 2021 | $7,995,000 | -32.7% | 612,180 | +1.0% | 0.17% | -28.5% |
Q2 2021 | $11,871,000 | -6.9% | 606,280 | +1.2% | 0.24% | -15.5% |
Q1 2021 | $12,747,000 | -12.6% | 599,280 | +22.2% | 0.28% | -10.0% |
Q4 2020 | $14,578,000 | +45.0% | 490,339 | +5.7% | 0.31% | +21.2% |
Q3 2020 | $10,057,000 | -11.9% | 464,086 | -9.4% | 0.26% | -18.5% |
Q2 2020 | $11,420,000 | +50.1% | 512,111 | +2.4% | 0.31% | -0.6% |
Q1 2020 | $7,610,000 | -3.9% | 500,000 | +44.9% | 0.32% | +26.0% |
Q4 2019 | $7,921,000 | +20.3% | 345,000 | +13.1% | 0.25% | -4.6% |
Q3 2019 | $6,585,000 | +27.4% | 305,000 | +29.8% | 0.26% | +40.1% |
Q2 2019 | $5,170,000 | -12.9% | 235,000 | +8.5% | 0.19% | -18.3% |
Q1 2019 | $5,934,000 | +2.0% | 216,500 | 0.0% | 0.23% | -16.7% |
Q4 2018 | $5,820,000 | -7.2% | 216,500 | +0.7% | 0.28% | +21.1% |
Q3 2018 | $6,272,000 | -6.7% | 215,000 | 0.0% | 0.23% | -12.4% |
Q2 2018 | $6,721,000 | +372.3% | 215,000 | +200.7% | 0.26% | +324.6% |
Q1 2018 | $1,423,000 | -31.5% | 71,500 | 0.0% | 0.06% | -35.1% |
Q4 2017 | $2,078,000 | – | 71,500 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |